| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.29▼ | 3.29▼ | 3.28▼ | 3.20▲ | 3.32▼ |
| MA10 | 3.29▼ | 3.30▼ | 3.22▲ | 3.35▼ | 3.98▼ |
| MA20 | 3.29▼ | 3.22▲ | 3.17▲ | 3.47▼ | 3.79▼ |
| MA50 | 3.30▼ | 3.18▲ | 3.26▲ | 4.19▼ | 2.14▲ |
| MA100 | 3.24▲ | 3.28▲ | 3.44▼ | 3.67▼ | 3.21▲ |
| MA200 | 3.18▲ | 3.46▼ | 3.76▼ | 2.37▲ | 7.02▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.005▲ | 0.027▲ | -0.012▼ | -0.203▼ |
| RSI | 42.933▼ | 55.706▲ | 54.621▲ | 40.593▼ | 50.444▲ |
| STOCH | 41.310 | 37.801 | 73.479 | 17.231▼ | 17.357▼ |
| WILL %R | -87.500▼ | -31.579 | -31.169 | -69.780 | -87.986▼ |
| CCI | -86.084 | 5.055 | 59.111 | -57.315 | -86.781 |
|
Friday, March 06, 2026 05:22 AM
Ironwood Pharmaceuticals’ IRWD sole marketed product, Linzess (linaclotide), is approved for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients aged ...
|
|
Thursday, February 26, 2026 07:40 AM
Ironwood Pharmaceuticals IRWD reported an adjusted loss of 1 cent per share for the fourth quarter of 2025, against the Zacks Consensus Estimate of earnings of 2 cents. The company had reported ...
|
|
Wednesday, February 25, 2026 09:15 AM
Ironwood Pharmaceuticals (IRWD) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.02 per share a year ago. These figures ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/03/26 | 3.18 | 3.40 | 3.18 | 3.29 | 2,856,554 |
| 20/03/26 | 3.20 | 3.25 | 3.015 | 3.04 | 14,227,618 |
| 19/03/26 | 3.14 | 3.26 | 3.055 | 3.23 | 3,414,655 |
| 18/03/26 | 3.22 | 3.305 | 3.13 | 3.17 | 3,238,153 |
| 17/03/26 | 3.37 | 3.52 | 3.05 | 3.25 | 10,411,615 |
| 16/03/26 | 3.44 | 3.498 | 3.33 | 3.37 | 1,684,017 |
| 13/03/26 | 3.40 | 3.5075 | 3.34 | 3.37 | 1,469,017 |
| 12/03/26 | 3.57 | 3.65 | 3.36 | 3.38 | 1,827,507 |
| 11/03/26 | 3.69 | 3.83 | 3.65 | 3.68 | 1,544,822 |
| 10/03/26 | 3.70 | 3.925 | 3.635 | 3.70 | 2,430,382 |
|
|
||||
|
|
||||
|
|